Induced expression of lectin-like oxidized ldl receptor-1 in vascular smooth muscle cells following Chlamydia pneumoniae infection and its down-regulation by fluvastatin

Acta Microbiologica et Immunologica Hungarica

Volumn 57, Issue 2, 2010, Pages 147-155

  Prochnau, D ^a   Rodel J ^a   Prager, Katrin ^a   Kuersten, Dana ^a   Heller, Regine ^a   Straube, E ^a   Figulla, H R ^a  

^a FRIEDRICH SCHILLER UNIVERSITY JENA   (Germany)

Author keywords

atherosclerosis; Chlamydia pneumoniae; LOX 1; smooth muscle cells; statins

Indexed keywords

FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; LECTIN RECEPTOR; OXIDIZED LOW DENSITY LIPOPROTEIN RECEPTOR; RNA;

ARTICLE; ATHEROSCLEROSIS; CHLAMYDOPHILA INFECTION; CHLAMYDOPHILA PNEUMONIAE; DOWN REGULATION; HEAT TREATMENT; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; IMMUNOBLOTTING; INOCULATION; LIPID STORAGE; LIPOPROTEIN BLOOD LEVEL; NONHUMAN; PROGNOSIS; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA EXTRACTION; SMOOTH MUSCLE FIBER; ULTRAVIOLET RADIATION; UPREGULATION; VASCULAR SMOOTH MUSCLE;

CHLAMYDOPHILA PNEUMONIAE;

EID: 77954443060     PISSN: 12178950     EISSN: 15882640     Source Type: Journal    
DOI: 10.1556/AMicr.57.2010.2.7     Document Type: Article

References (21)

1. Libby, P., Ridker, P. M., Maseri, A.: Inflammation and atherosclerosis. Circulation 105, 1135-1143 (2002).
2. Smeeth, I., Thomas, S. L., Hall, A. J., Hubbard, R., Farrington, P., Vallance, P.: Risk of myocardial infarction and stroke after acute infection or vaccination. N. Engl. J. Med. 351, 2611-2618 (2004).
3. Ngeh, J., Anand, V., Gupta, S.: Chlamydia pneumoniae and atherosclerosis - what we know and what we don't. Clin. Microbiol. Infect. 8, 2-13 (2002).
4. Cleland, J. G., Huan, L. P., Freemantle, N., Clark, A. L., Coletta, A. P.: Clinical trials update from the European Society of Cardiology: SENIORS, ACES, PROVE-IT, ACTION, and the HF-ACTION trial. Eur. J. Heart Fail. 6, 787-791 (2004).
5. O'Connor, C. M., Dunne, M. W., Pfeffer ,M. A., Muhlestein, J. B., Yao, L., Gupta, S. et al.: Investigators in the WIZARD study, azithromycin for the secondary prevention of coronary heart disease events: the WIZARD study: a randomised controlled trial. JAMA 290, 1459-1466 (2003).
6. Chen, S., Sorrentino, R., Shimada, K., Bulut, Y., Doherty, T. M., Crother, T. R. et al.: Chlamydia pneumoniae-induced foam cell formation requires MyD88-dependent and -independent signaling and is reciprocally modulated by liver X receptor activation. J. Immun. 181, 7186-7193 (2008).
7. Ross, R.: Atherosclerosis - an inflammatory disease. N. Engl. J. Med. 340, 115-146 (1999).
8. Krieger, M.: Molecular flypaper and atherosclerosis: Structure of the macrophage scavenger receptor. Trends Biochem. Sci. 17, 141-146 (1992).
9. Sawamura, T., Kume, N., Aoyama, T., Moriwaki, H., Hoshikawa, H., Aiba, Y. et al.: A novel receptor for oxidized low density lipoprotein. Nature 386, 73-77 (1997).
10. Aoyama, T., Chen, M., Fujiwara, H., Masaki, T., Sawamura, T.: LOX-1 mediates Lysophosphatidylcholine-induced oxidized LDL uptake in smooth muscle cells. FEBS Letters 467, 217-220 (2000).
11. Hiltunen, T. P., Luoma, J. S., Nikkari, T., Ylä-Herttuala, S.: Expression of LDL receptor, VLDL receptor, LDL receptor-related protein, an scavenger receptor in rabbit atherosclerotic lesions. Circulation 97, 1079-1086 (1998).
12. Rödel, J., Woytas, M., Groh, A., Schmidt, K. H., Hartmann, M., Lehmann, M. et al.: Production of basic fibroblast growth factor and interleukin 6 by human smooth muscle cells following infection with Chlamydia pneumoniae. Infect. Immun. 68, 3635-3641 (2000).
13. Maingrette, F., Renier, G.: Linoleic acid increases lectin-like oxidized LDL receptor-1 (LOX-1) expression in human aortic endothelial cells. Diabetes 54, 1506-1513 (2005).
14. Draude, G., Hrboticky, N., Lorenz, R. L.: The expression of the lectin-like oxidized low-density lipoprotein receptor (LOX-1) on human vascular smooth muscle cells and monocytes and its down-regulation by lovastatin. Biochem. Pharmacol. 57, 383-386 (1999).
15. Kataoka, H., Kume, N., Miyamoto, S., Minami, M., Moriwaki, H., Murase, T. et al.: Expression of lectinlike oxidized low-density lipoprotein receptor-1 in human atherosclerotic lesions. Circulation 99, 3110-3117 (1999).
16. Yoshida, T., Koide, N., Mori, I., Ito, H., Yokochi, T.: Chlamydia pneumoniae infection enhances lectin-like oxidized low-density lipoprotein receptor (LOX-1) expression on human endothelial cells. FEMS Microbiol. Lett. 260, 17-22 (2006).
17. Blessing, E., Campbell, L. A., Rosenfeld, M. E., Chough, N., Kuo, C. C.: Chlamydia pneumoniae infection accelerates hyperlipidemia induced atherosclerotic lesion development in C57BL/6J mice. Atherosclerosis 158, 13-17 (2001).
18. Dittrich, R., Dragonas, C., Mueller, A., Maltaris, T., Rupp, J., Beckmann, M. W. et al.: Endothelial Chlamydia pneumoniae infection promotes oxidation of LDL. Biochem. Biophys. Res. Comm. 319, 501-505 (2004).
19. Chai, Y. C., Howe, P. J., DiCorleto, P. E., Chisolms, G. M.: Oxidized low density lipoprotein and lysophosphatidylcholine stimulate cell cycle entry in vascular smooth muscle cells. Evidence for release of fibroblast growth factor-2. J. Biol. Chem. 271, 17791-17797 (1996).
20. Shor, A., Phillips, J. I.: Histopathological and ultrastructural findings suggesting an initiating role for Chlamydia pneumoniae in the pathogenesis of atherosclerosis. Cardiovasc. J. South Afr. 11, 16-23 (2000).
21. Vaughan, C. J., Murphy, M. B., Buckley, B. M.: Statins do more than lower cholesterol. Lancet 348, 1079-1082 (1996).